Evidence map›Paper›PMID 29566086›Full record

ArticlePloS one2018

Mild hypothermia upregulates myc and xbp1s expression and improves anti-TNFα production in CHO cells.

Mauro Torres, Roberto Zúñiga, Matias Gutierrez, Mauricio Vergara, Norberto Collazo, Juan Reyes, Julio Berrios, Juan Carlos Aguillon, Maria Carmen Molina, Claudia Altamirano

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Mauro TorresEscuela de Ingeniería Bioquímica, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile.
Roberto ZúñigaCentro de InmunoBiotecnología, Programa D. de Inmunología, Instituto de Ciencias Biomédica (ICBM), Facultad de Medicina, Universidad de Chile, Santiago, Chile.
Matias GutierrezCentro de InmunoBiotecnología, Programa D. de Inmunología, Instituto de Ciencias Biomédica (ICBM), Facultad de Medicina, Universidad de Chile, Santiago, Chile.
Mauricio VergaraEscuela de Ingeniería Bioquímica, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile.
Norberto CollazoCentro de InmunoBiotecnología, Programa D. de Inmunología, Instituto de Ciencias Biomédica (ICBM), Facultad de Medicina, Universidad de Chile, Santiago, Chile.
Juan ReyesInstituto de Química, Pontificia Universidad Católica de Valparaíso, Valparaiso, Chile.
Julio BerriosEscuela de Ingeniería Bioquímica, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile.
Juan Carlos AguillonCentro de InmunoBiotecnología, Programa D. de Inmunología, Instituto de Ciencias Biomédica (ICBM), Facultad de Medicina, Universidad de Chile, Santiago, Chile.
Maria Carmen MolinaCentro de InmunoBiotecnología, Programa D. de Inmunología, Instituto de Ciencias Biomédica (ICBM), Facultad de Medicina, Universidad de Chile, Santiago, Chile.
Claudia AltamiranoEscuela de Ingeniería Bioquímica, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile.ORCID 0000-0003-4448-9074
Pontificia Universidad Católica de Valparaíso · CLUniversity of Chile · CLUniversidad ORT Uruguay · UY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chinese hamster ovary (CHO) cells are the most frequently used host for commercial production of therapeutic proteins. However, their low protein productivity in culture is the main hurdle to overcome. Mild hypothermia has been established as an effective strategy to enhance protein specific productivity, although the causes of such improvement still remain unclear. The self-regulation of global transcriptional regulatory factors, such as Myc and XBP1s, seems to be involved in increased the recombinant protein production at low temperature. This study evaluated the impact of low temperature in CHO cell cultures on myc and xbp1s expression and their effects on culture performance and cell metabolism. Two anti-TNFα producing CHO cell lines were selected considering two distinct phenotypes: i.e. maximum cell growth, (CN1) and maximum specific anti-TNFα production (CN2), and cultured at 37, 33 and 31°C in a batch system. Low temperature led to an increase in the cell viability, the expression of the recombinant anti-TNFα and the production of anti-TNFα both in CN1 and CN2. The higher production of anti-TNFα in CN2 was mainly associated with the large expression of anti-TNFα. Under mild hypothermia myc and xbp1s expression levels were directly correlated to the maximal viable cell density and the specific anti-TNFα productivity, respectively. Moreover, cells showed a simultaneous metabolic shift from production to consumption of lactate and from consumption to production of glutamine, which were exacerbated by reducing culture temperature and coincided with the increased anti-TNFα production. Our current results provide new insights of the regulation of myc and xbp1s in CHO cells at low temperature, and suggest that the presence and magnitude of the metabolic shift might be a relevant metabolic marker of productive cell line.

Indexed as

Cold TemperatureAnimalsAntibodies, MonoclonalBiotechnologyCell Culture TechniquesCell ProliferationCell SurvivalCHO CellsCricetinaeCricetulusHumansProto-Oncogene Proteins c-mycRecombinant ProteinsTumor Necrosis Factor-alphaUp-RegulationX-Box Binding Protein 1Antibodies, MonoclonalProto-Oncogene Proteins c-mycRecombinant ProteinsTNF protein, humanTumor Necrosis Factor-alphaX-Box Binding Protein 1

Identifiers

PMID29566086
PMCPMC5864046
OpenAlexW2790262422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.